Dr. Michael G. Tyshenko is a Senior Health Risk Analyst at Risk Sciences International (RSI), where he has contributed since 2018 to some of the organization’s most complex and cross-cutting public health risk projects. As RSI’s lead on chemical peer reviews, he brings extensive experience in regulatory science, biological risk, and science-policy integration to high-stakes evaluations that require both deep expertise and clear communication.

In Memoriam, Dr. Donald Mattison (1944-2026) Dr. Donald Mattison passed away at his home in Columbia, South Carolina on Sunday, March 22, with his family present. Don joined Risk Sciences International (RSI) in 2012 as Vice President and Chief Medical Officer, following a distinguished career spanning government, academia, and clinical practice in the United States. During his time at RSI, he contributed to 47 scientific publications and served as a trusted mentor and colleague to many across the organization.

Dr. Emma Hartnett is Vice-President, Risk Modelling and Simulation at Risk Sciences International (RSI), where she has been a foundational member since its inception in 2006. A globally recognized authority in quantitative risk assessment (QRA), she specializes in developing risk models and decision support tools for complex public health and safety challenges across biological, chemical, and environmental domains.

As a Senior Advisor and Associate Expert with Risk Sciences International, Dr. Leiss contributes unparalleled insight into the design, delivery, and evaluation of risk communication strategies for government, regulatory bodies, and civil society. His legacy work in building public trust around controversial science and his decades of thought leadership on consensus-building, science-based policy, and societal responses to risk make him a foundational contributor to RSI’s mission.

Cemil ‘Jim’ Alyanak joined Risk Sciences International (RSI) in 2018 and serves as Vice-President, Communications and Strategic Initiatives. In this senior leadership role, he leads RSI’s risk communications practice, drives cross-cutting initiatives, advances strategic in-house projects, and expands the company’s international presence and partnerships. As creator of CRAFT (the Collective Risk Action Framework and Toolkit) and the Global Risk Census, Alyanak has helped establish RSI as a global innovator in stakeholder- and constituency-centered risk engagement. His expertise in perception analysis and communications strategy enables RSI to address complex challenges across public health, regulatory affairs, environmental risk, and humanitarian crisis response. From pandemic-era messaging to multistakeholder workshops and regulator support, his work consistently focuses on aligning message, audience, and outcomes that can be measured. Recognized for his ability to navigate cross-cultural contexts and indigenous knowledge systems, Alyanak has worked extensively on in-region projects with local and indigenous communities worldwide. This grassroots experience informs his current portfolio, which includes collaboration and consensus-building projects that unite stakeholders and constituencies in addressing both shared and similar risks. He also provides regional, federal, and international policy guidance to companies and governing bodies seeking to design risk-informed policies, instruments, and frameworks. Drawing on extensive emergency preparedness and disaster response experience, Alyanak now leads RSI’s Disaster and Emergency-related projects, advancing practical, risk-based solutions to complex emergencies and strengthening resilience across sectors.

Dr. Natalia (Natasha) Shilnikova is a Senior Health Risk Analyst at Risk Sciences International (RSI), where she has contributed since 2011 to some of the organization’s most analytically demanding and policy-relevant projects. With a background in medicine and a PhD in medical sciences, Dr. Shilnikova specializes in the synthesis of epidemiological evidence, human health risk assessment, toxicology, and critical literature reviews—applying her expertise across a spectrum of regulatory and public health priorities.

Dr. Franco Momoli joined Risk Sciences International (RSI) in 2019 and currently serves as Vice-President, Chemical and Product Safety. In this role, he leads a multidisciplinary team of epidemiologists, risk assessors, toxicologists, and biostatisticians in conducting human health risk assessments related to environmental contaminants and consumer products. His practice group supports government agencies, regulatory bodies, and international partners in making science-informed decisions that safeguard public health.

Since joining Risk Sciences International in 2019, Martin has served in Business Development, leading RSI’s business expansion efforts across Canadian and global markets. He is instrumental in identifying and qualifying opportunities, coordinating multidisciplinary proposal teams, developing project frameworks, and supporting contract negotiations. His expertise spans the entire procurement spectrum, including competitive tenders, standing offers, supply arrangements, and unsolicited proposals.

Dr. Nataliya Karyakina is a Senior Toxicologist and Health Risk Analyst at Risk Sciences International (RSI), where she has served since 2008. She plays a central role in RSI’s work at the intersection of chemical safety, regulatory science, and human health. Drawing on more than three decades of experience, Dr. Karyakina contributes to complex projects involving the evaluation and assessment of hazardous properties of chemicals with different modes of action, hazard-based classification of chemical substances under CLP (EC) 1272/2008, and the development of health-based safety values for industrial and environmental chemicals for both workers and the general population.

Dr. Paul Price is a Senior Analyst at Risk Sciences International (RSI), bringing over four decades of experience as a pioneer in exposure science and chemical risk assessment. Since joining RSI in 2019, Dr. Price has focused on advancing mixture risk assessment—an increasingly vital area as regulators shift from assessing single chemicals in isolation to understanding the cumulative effects of combined exposures. His current work includes the development of Mixture Adjustment Factors, participation in international regulatory committees, and authorship of scholarly publications aimed at refining the science-policy interface of chemical mixture risk.